Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $359.05 | $19.76 | 1,717.27% | 7,181.00x | 105.99x | 7.96x | 9.63x | 6.93x | $529.27M | 1.34% | $4.13B | 37.48 | $37.64B | 118.35 | ||
| NVO | NOVO NORDISK A S | $49.23 | $152.89 | -67.80% | 13.49x | 2.16x | 4.50x | 7.16x | 0.14x | $9.33B | 4.24% | $30.70B | 6.88 | $236.35B | 9.79 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $45.39 | $18.15 | 150.13% | 92.63x | 28.46x | 5.67x | 6.43x | 1.12x | $101.73M | 3.00% | $535.38M | 7.17 | $3.28B | 61.13 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.65 | $16.84 | -48.64% | 18.02x | 15.28x | 5.74x | 3.66x | 0.23x | -$23.64M | -4.89% | $133.17M | 2.38 | $495.25M | 7.37 | ||
| CORT | CORCEPT THERAPEUTICS INC | $39.82 | $42.70 | -6.74% | 39.82x | 64.35x | 5.56x | 6.63x | 0.41x | $162.57M | 3.94% | $631.90M | 6.10 | $4.07B | 61.69 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $332.68 | $109.56 | 203.65% | 139.20x | 49.66x | 11.73x | 55.91x | 1.31x | $465.38M | 1.07% | $789.18M | 6.02 | $45.43B | 71.95 | ||
| VCEL | VERICEL CORP | $37.41 | $9.80 | 281.62% | 143.88x | 66.00x | 7.30x | 5.88x | 1.70x | $20.38M | 1.08% | $321.86M | 6.38 | $1.89B | 64.47 | ||
| ARGX | ARGENX SE | $845.35 | $379.38 | 122.83% | 33.78x | 28.20x | 27,269.35x | 7.19x | 1.37x | $467.72M | 0.91% | $7.17B | 117.50 | $49.19B | 60.63 | ||
| GMAB | GENMAB A | $29.16 | $106.76 | -72.69% | 18.81x | 1.73x | 5.04x | 3.20x | 0.11x | $1.13B | 6.04% | $5.85B | 9.10 | $22.44B | 14.54 | ||
| KRYS | KRYSTAL BIOTECH INC | $283.29 | $122.15 | 131.93% | 40.01x | 34.02x | 21.07x | 6.79x | 1.32x | $189.35M | 2.31% | $1.22B | 42.14 | $7.79B | 39.76 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $189.94 | $74.10 | 156.33% | 82.23x | 22.45x | 14.80x | 3.93x | 1.18x | $30.76M | 0.83% | $950.17M | 48.53 | $4.05B | 39.31 | ||
| TECH | BIO-TECHNE CORP | $59.33 | $16.86 | 251.94% | 114.10x | 29.37x | 7.61x | 4.62x | 1.62x | $223.02M | 2.41% | $2.01B | 12.90 | $9.46B | 41.78 | ||
| ADMA | ADMA BIOLOGICS INC | $15.99 | $13.06 | 22.47% | 18.17x | 17.52x | 7.81x | 8.83x | 0.76x | $40.73M | 1.07% | $431.19M | 1.81 | $3.82B | 22.18 | ||
| MNKD | MANNKIND CORP | $5.44 | $3.00 | 81.03% | 54.40x | 62.31x | 5.32x | -37.49x | 0.85x | $43.39M | 2.59% | -$44.55M | -0.15 | $1.90B | 26.00 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.12 | $19.59 | -73.86% | 3.22x | -94.99x | 731.43x | 1.62x | 0.19x | -$82.36M | -29.65% | $171.23M | 3.16 | $218.34M | 2.43 | ||
| HALO | HALOZYME THERAPEUTICS INC | $73.23 | $74.28 | -1.42% | 27.74x | 8.79x | 6.28x | 177.05x | 0.47x | $644.59M | 7.35% | $48.81M | 0.41 | $10.65B | 18.58 | ||
| RPRX | ROYALTY PHARMA PLC | $45.34 | $48.33 | -6.18% | 25.33x | 8.74x | 8.19x | 2.69x | 0.45x | $2.22B | 11.39% | $9.71B | 22.60 | $34.49B | 31.97 | ||
| VCYT | VERACYTE INC | $36.61 | $12.75 | 187.18% | 93.87x | 32.40x | 5.82x | 2.30x | 1.32x | $98.21M | 3.41% | $1.26B | 15.98 | $2.62B | 45.92 | ||
| XOMA | XOMA ROYALTY CORP | $24.35 | $16.24 | 49.90% | 30.06x | 77.45x | 6.27x | 3.43x | 0.80x | -$12.41M | -4.20% | $87.94M | 7.25 | $342.96M | 12.82 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $5.00 | $4.43 | 12.82% | 18.52x | 16.62x | 3.20x | 5.65x | 0.66x | $21.15M | 5.30% | $70.68M | 0.89 | $337.80M | 14.89 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.98 | $3.66 | -18.66% | 42.57x | 16.86x | 3.82x | 4.53x | 0.34x | -$11.69M | -4.93% | $52.91M | 0.67 | $234.19M | 26.40 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $35.28 | $64.93 | -45.66% | 10.92x | 8.16x | 2.46x | 2.43x | 0.29x | $296.89M | 14.62% | $835.12M | 14.51 | $1.55B | 5.76 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $24.29 | $24.09 | 0.83% | 13.57x | 13.38x | 5.15x | 3.24x | 0.67x | $234.54M | 7.88% | $920.25M | 7.51 | $2.30B | 7.10 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $14.31 | $10.09 | 41.76% | 24.67x | 15.00x | 7.09x | 5.16x | 0.81x | $119.87M | 6.35% | $365.77M | 2.78 | $1.89B | 18.27 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $22.20 | $6.31 | 252.00% | 63.43x | -19.32x | 2.76x | 7.00x | 1.97x | $78.64M | 2.80% | $401.17M | 3.17 | $2.80B | 30.03 | ||
| CRMD | CORMEDIX INC | $7.17 | $14.90 | -51.89% | 3.16x | 4.41x | 2.54x | 1.51x | 1.77x | $74.42M | 13.67% | $374.13M | 4.93 | $665.35M | 5.93 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $792.16 | $457.42 | 73.18% | 18.39x | 17.05x | 5.78x | 2.68x | 1.46x | $4.08B | 4.92% | $31.26B | 298.82 | $83.33B | 14.32 | ||
| UTHR | UNITED THERAPEUTICS CORP | $476.05 | $261.53 | 82.03% | 16.72x | 16.15x | 6.67x | 3.11x | 1.91x | $1.12B | 5.38% | $6.59B | 150.46 | $19.16B | 10.80 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $61.83 | $52.59 | 17.56% | 22.73x | 13.95x | 3.84x | 1.96x | 0.64x | $832.13M | 7.01% | $6.06B | 31.54 | $11.22B | 14.53 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $23.20 | $12.49 | 85.80% | 14.78x | 30.33x | 3.74x | 4.28x | 2.70x | $197.81M | 5.05% | $917.27M | 5.43 | $3.70B | 12.86 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $470.31 | $193.33 | 143.27% | 30.42x | 23.07x | 10.02x | 6.40x | 1.73x | $3.19B | 2.66% | $18.67B | 73.00 | $116.24B | 23.89 | ||
| INVA | INNOVIVA INC | $23.66 | $19.89 | 18.98% | 12.52x | 10.83x | 4.21x | 1.75x | 1.02x | $196.54M | 12.03% | $1.01B | 14.63 | $1.55B | 7.22 | ||
| EXEL | EXELIXIS INC | $44.47 | $36.74 | 21.04% | 15.44x | 13.68x | 5.21x | 5.34x | 0.85x | $875.84M | 7.25% | $2.16B | 7.96 | $11.24B | 11.30 | ||
| MDXG | MIMEDX GROUP INC | $5.22 | $2.75 | 89.76% | 18.64x | 46.52x | 1.96x | 3.24x | 1.78x | $66.82M | 8.64% | $238.95M | 1.61 | $649.22M | 9.38 | ||
| INCY | INCYTE CORP | $102.99 | $77.10 | 33.57% | 15.63x | 12.86x | 3.91x | 3.97x | 1.01x | $1.35B | 6.74% | $5.17B | 26.47 | $17.43B | 9.90 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.